1 2867 121 YOGA-BASED LIFESTYLE TREATMENT AND COMPOSITE TREATMENT GOALS IN TYPE 2 DIABETES IN A RURAL SOUTH INDIAN SETUP- A RETROSPECTIVE STUDY. THIS MULTICENTRE RETROSPECTIVE STUDY EXAMINED THE EFFECTS OF ADJUNCT YOGA-TREATMENT IN ACHIEVING COMPOSITE CARDIOVASCULAR GOALS FOR TYPE 2 DIABETES (T2D), SET FORTH BY THE AMERICAN DIABETES ASSOCIATION (ADA) IN RURAL INDIAN SETTINGS. RECORDS WERE EXTRACTED FOR 146 T2D PATIENTS, AGED >/=20-70 YEARS, AND TREATED UNDER THE "APOLLO TOTAL HEALTH PROGRAMME" FOR RURAL DIABETES MANAGEMENT, FOR THE PERIOD APRIL 2016 TO NOVEMBER 2016. THE STUDY COHORT COMPRISED OF TWO TREATMENT GROUPS (N = 73 EACH); NON-YOGA GROUP (STANDARD OF CARE) AND YOGA GROUP (ADJUNCT YOGA-TREATMENT). PROPENSITY SCORE MATCHING WAS APPLIED BETWEEN THE STUDY GROUPS TO DEFINE THE COHORT. COMPOSITE CARDIOVASCULAR SCORES WERE BASED ON THE COMBINATION OF INDIVIDUAL ADA GOALS; A1C < 7%, BLOOD PRESSURE (BP) < 140/90 MMHG, STRINGENT BP (<130/80 MMHG) AND LIPID, LDL-C < 100 MG/DL [RISK FACTOR FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE]. LOGISTIC REGRESSION WAS USED TO COMPARE BETWEEN THE TWO TREATMENT GROUPS. COMPARED TO STANDARD OF CARE, ADJUNCT YOGA-TREATMENT WAS FOUND TO SIGNIFICANTLY FACILITATE THE ATTAINMENT OF ADA COMPOSITE SCORE BY 8-FOLD; A1C, ~2-FOLD; LDL-C, ~2-FOLD; BP < 140/90 MMHG AND <130/80 MMHG BY ~8-AND ~6-FOLD RESPECTIVELY. THIS STUDY PROVIDES THE FIRST EVIDENCE FOR SIGNIFICANT EFFICACY OF ADJUNCT YOGA-TREATMENT FOR THE ATTAINMENT OF FAVOURABLE TREATMENT GOALS FOR T2D IN RURAL INDIAN SETTINGS. CLINICAL TRIAL REGISTRATION NUMBER: CTRI/2020/02/0232790. 2020 2 2583 28 YOGA FOR HEART RATE VARIABILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS. THE OBJECTIVE OF THIS SYSTEMATIC REVIEW IS TO SUMMARIZE AND CRITICALLY ASSESS THE EFFECTS OF YOGA ON HEART RATE VARIABILITY (HRV). NINE DATABASES WERE SEARCHED FROM THEIR INCEPTIONS TO JUNE 2014. WE INCLUDED RANDOMIZED CLINICAL TRIALS (RCTS) COMPARING YOGA AGAINST ANY TYPE OF CONTROL INTERVENTION IN HEALTHY INDIVIDUALS OR PATIENTS WITH ANY MEDICAL CONDITION. RISK OF BIAS WAS ASSESSED USING THE COCHRANE CRITERIA. TWO REVIEWERS PERFORMED THE SELECTION OF STUDIES, DATA EXTRACTION, AND QUALITY ASSESSMENTS INDEPENDENT OF ONE ANOTHER. FOURTEEN TRIALS MET THE INCLUSION CRITERIA. ONLY TWO OF THEM WERE OF ACCEPTABLE METHODOLOGICAL QUALITY. TEN RCTS REPORTED FAVOURABLE EFFECTS OF YOGA ON VARIOUS DOMAINS OF HRV, WHEREAS NINE OF THEM FAILED TO DO SO. ONE RCT DID NOT REPORT BETWEEN-GROUP COMPARISONS. THE META-ANALYSIS (MA) OF TWO TRIALS DID NOT SHOW FAVOURABLE EFFECTS OF YOGA COMPARED TO USUAL CARE ON E:I RATIO (N = 61, SMDS = 0.63; 95% CIS [-0.72 TO 1.99], P = 0.36; HETEROGENEITY: R(2) = 0.79, CHI(2) = 5.48, DF = 1, (P = 0.02); I(2) = 82%). THE MA ALSO FAILED TO SHOW STATISTICALLY SIGNIFICANT DIFFERENCES BETWEEN THE GROUPS REGARDING THE 30:15 RATIO (N = 61, SMDS = 0.20; 95% CIS [-0.43 TO 0.84], P = 0.53; HETEROGENEITY: R(2) = 0.07, CHI(2) = 1.45, DF = 1, (P = 0.23); I(2) = 31%). THE DATA FROM THE REMAINING RCTS WERE TOO HETEROGENEOUS FOR POOLING. THESE RESULTS PROVIDE NO CONVINCING EVIDENCE FOR THE EFFECTIVENESS OF YOGA IN MODULATING HRV IN PATIENTS OR HEALTHY SUBJECTS. FUTURE INVESTIGATIONS IN THIS AREA SHOULD OVERCOME THE MULTIPLE METHODOLOGICAL WEAKNESSES OF THE PREVIOUS RESEARCH. 2015 3 2629 40 YOGA FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE. BACKGROUND: A SEDENTARY LIFESTYLE AND STRESS ARE MAJOR RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD). SINCE YOGA INVOLVES EXERCISE AND IS THOUGHT TO HELP IN STRESS REDUCTION IT MAY BE AN EFFECTIVE STRATEGY IN THE PRIMARY PREVENTION OF CVD. OBJECTIVES: TO DETERMINE THE EFFECT OF ANY TYPE OF YOGA ON THE PRIMARY PREVENTION OF CVD. SEARCH METHODS: WE SEARCHED THE FOLLOWING ELECTRONIC DATABASES: THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL) (2013, ISSUE 11) IN THE COCHRANE LIBRARY; MEDLINE (OVID) (1946 TO NOVEMBER WEEK 3 2013); EMBASE CLASSIC + EMBASE (OVID) (1947 TO 2013 WEEK 48); WEB OF SCIENCE (THOMSON REUTERS) (1970 TO 4 DECEMBER 2013); DATABASE OF ABSTRACTS OF REVIEWS OF EFFECTS (DARE), HEALTH TECHNOLOGY ASSESSMENT DATABASE AND HEALTH ECONOMICS EVALUATIONS DATABASE (ISSUE 4 OF 4, 2013) IN THE COCHRANE LIBRARY. WE ALSO SEARCHED A NUMBER OF ASIAN DATABASES AND THE ALLIED AND COMPLEMENTARY MEDICINE DATABASE (AMED) (INCEPTION TO DECEMBER 2012). WE SEARCHED TRIAL REGISTERS AND REFERENCE LISTS OF REVIEWS AND ARTICLES, AND APPROACHED EXPERTS IN THE FIELD. WE APPLIED NO LANGUAGE RESTRICTIONS. SELECTION CRITERIA: RANDOMISED CONTROLLED TRIALS LASTING AT LEAST THREE MONTHS INVOLVING HEALTHY ADULTS OR THOSE AT HIGH RISK OF CVD. TRIALS EXAMINED ANY TYPE OF YOGA AND THE COMPARISON GROUP WAS NO INTERVENTION OR MINIMAL INTERVENTION. OUTCOMES OF INTEREST WERE CLINICAL CVD EVENTS AND MAJOR CVD RISK FACTORS. WE DID NOT INCLUDE ANY TRIALS THAT INVOLVED MULTIFACTORIAL LIFESTYLE INTERVENTIONS OR WEIGHT LOSS. DATA COLLECTION AND ANALYSIS: TWO AUTHORS INDEPENDENTLY SELECTED TRIALS FOR INCLUSION, EXTRACTED DATA AND ASSESSED THE RISK OF BIAS. MAIN RESULTS: WE IDENTIFIED 11 TRIALS (800 PARTICIPANTS) AND TWO ONGOING STUDIES. STYLE AND DURATION OF YOGA DIFFERED BETWEEN TRIALS. HALF OF THE PARTICIPANTS RECRUITED TO THE STUDIES WERE AT HIGH RISK OF CVD. MOST OF STUDIES WERE AT RISK OF PERFORMANCE BIAS, WITH INADEQUATE DETAILS REPORTED IN MANY OF THEM TO JUDGE THE RISK OF SELECTION BIAS.NO STUDY REPORTED CARDIOVASCULAR MORTALITY, ALL-CAUSE MORTALITY OR NON-FATAL EVENTS, AND MOST STUDIES WERE SMALL AND SHORT-TERM. THERE WAS SUBSTANTIAL HETEROGENEITY BETWEEN STUDIES MAKING IT IMPOSSIBLE TO COMBINE STUDIES STATISTICALLY FOR SYSTOLIC BLOOD PRESSURE AND TOTAL CHOLESTEROL. YOGA WAS FOUND TO PRODUCE REDUCTIONS IN DIASTOLIC BLOOD PRESSURE (MEAN DIFFERENCE (MD) -2.90 MMHG, 95% CONFIDENCE INTERVAL (CI) -4.52 TO -1.28), WHICH WAS STABLE ON SENSITIVITY ANALYSIS, TRIGLYCERIDES (MD -0.27 MMOL/L, 95% CI -0.44 TO -0.11) AND HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL (MD 0.08 MMOL/L, 95% CI 0.02 TO 0.14). HOWEVER, THE CONTRIBUTING STUDIES WERE SMALL, SHORT-TERM AND AT UNCLEAR OR HIGH RISK OF BIAS. THERE WAS NO CLEAR EVIDENCE OF A DIFFERENCE BETWEEN GROUPS FOR LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL (MD -0.09 MMOL/L, 95% CI -0.48 TO 0.30), ALTHOUGH THERE WAS MODERATE STATISTICAL HETEROGENEITY. ADVERSE EVENTS, OCCURRENCE OF TYPE 2 DIABETES AND COSTS WERE NOT REPORTED IN ANY OF THE INCLUDED STUDIES. QUALITY OF LIFE WAS MEASURED IN THREE TRIALS BUT THE RESULTS WERE INCONCLUSIVE. AUTHORS' CONCLUSIONS: THE LIMITED EVIDENCE COMES FROM SMALL, SHORT-TERM, LOW-QUALITY STUDIES. THERE IS SOME EVIDENCE THAT YOGA HAS FAVOURABLE EFFECTS ON DIASTOLIC BLOOD PRESSURE, HDL CHOLESTEROL AND TRIGLYCERIDES, AND UNCERTAIN EFFECTS ON LDL CHOLESTEROL. THESE RESULTS SHOULD BE CONSIDERED AS EXPLORATORY AND INTERPRETED WITH CAUTION. 2014 4 1491 25 INTERLEUKIN-6, VITAMIN D & DIABETES RISK-FACTORS MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE INDIVIDUALS. BACKGROUND & OBJECTIVES: SEVERAL DIABETES PREVENTION PROGRAMMES HAVE DEMONSTRATED A REDUCTION IN INCIDENCE OF DIABETES IN INDIVIDUALS WITH PREDIABETES THROUGH WEIGHT LOSS. SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES HAVE ALSO BEEN SHOWN TO BE EFFICACIOUS IN WEIGHT LOSS. THIS STUDY WAS UNDERTAKEN TO INVESTIGATE IF INTERLEUKIN (IL)-6, VITAMIN D, NEOPTERIN, VASPIN, AND DIABETES RISK FACTORS CAN BE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE SUBJECTS. METHODS: IN THIS PILOT STUDY, 34 OVERWEIGHT/OBESE [BODY MASS INDEX (BMI) >/= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS. 2015 5 811 26 EFFECT OF YOGA ON BLOOD PRESSURE IN PREHYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS. INTRODUCTION: PREHYPERTENSION IS A PRECURSOR FOR DEVELOPING HYPERTENSION AND IS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. YOGA THERAPY MAY HAVE A ROLE IN LOWERING THE BLOOD PRESSURES IN PREHYPERTENSION AND HYPERTENSION. THIS SYSTEMATIC REVIEW AIMS TO SYNTHESIZE THE AVAILABLE LITERATURE FOR THE SAME. METHODOLOGY. DATABASES SUCH AS PUBMED, EMBASE, SCOPUS, AND WEB OF SCIENCE WERE SEARCHED FOR RANDOMISED CONTROL TRIALS ONLY IN THE TIME DURATION OF 2010-2021. THE MAIN OUTCOME OF INTEREST WAS SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. ARTICLES WERE SCREENED BASED ON THE INCLUSION CRITERIA, AND 8 ARTICLES WERE RECRUITED FOR THE REVIEW. META-ANALYSIS WAS DONE FOR SUITABLE ARTICLES. REVMAN 5.4 BY COCHRANE WAS USED FOR META-ANALYSIS AND FOREST PLOT CONSTRUCTION. RISK OF BIAS WAS DETERMINED USING THE DOWNS AND BLACK CHECKLIST BY THREE INDEPENDENT AUTHORS. RESULTS: THE META-ANALYSIS OF THE ARTICLES FAVOURED YOGA INTERVENTION OVER THE CONTROL INTERVENTION. YOGA THERAPY HAD SIGNIFICANTLY REDUCED THE SYSTOLIC PRESSURE (-0.62 STANDARD MEAN DIFFERENCE, AT IV FIXED 95% CI: -0.83, -0.41) AND DIASTOLIC PRESSURE (-0.81 STANDARD MEAN DIFFERENCE, AT IV RANDOM 95% CI: -1.39, -0.22). SECONDARY OUTCOME MEASURES STUDIED WERE HEART RATE, WEIGHT, BMI, WAIST CIRCUMFERENCE, AND LIPID PROFILE. THE MAIN PROTOCOL OF YOGA THERAPY INCLUDED POSTURES, BREATHING EXERCISES, AND DIFFERENT MEDITATION TECHNIQUES. A SIGNIFICANT REDUCTION IN SECONDARY OUTCOMES WAS OBSERVED, EXCEPT FOR HDL VALUES IN LIPID PROFILE WHICH SHOWED A GRADUAL INCREASE IN YOGA GROUP IN COMPARISON WITH ALTERNATIVE THERAPY. CONCLUSION: YOGA THERAPY HAS SHOWN TO BE SIGNIFICANT IN THE REDUCTION OF SYSTOLIC AND DIASTOLIC PRESSURE IN PREHYPERTENSIVE POPULATION. SUPPORTING EVIDENCE LACKS IN PROVIDING A PROPER STRUCTURED DOSAGE OF YOGA ASANAS AND BREATHING TECHNIQUES. CONSIDERING THE EXISTING LITERATURE AND EVIDENCE, YOGA THERAPY CAN BE USED AND RECOMMENDED IN PREHYPERTENSIVE POPULATION AND CAN BE BENEFICIAL IN REDUCING THE CHANCES OF DEVELOPING HYPERTENSION OR CARDIOVASCULAR DISEASES. 2021 6 859 27 EFFECT OF YOGA PRACTICE ON LEVELS OF INFLAMMATORY MARKERS AFTER MODERATE AND STRENUOUS EXERCISE. BACKGROUND AND OBJECTIVES: TO EVALUATE THE EFFECT OF YOGA PRACTICE AND EXERCISE CHALLENGE ON TUMOUR NECROSIS FACTOR ALPHA (TNF-ALPHA), INTERLEUKIN-6 (IL-6) LEVELS AND LIPID PROFILE. MATERIALS AND METHODS: TWO HUNDRED AND EIGHTEEN SUBJECTS PARTICIPATED IN THE STUDY. ONE HUNDRED AND NINE VOLUNTEERS (51 MALES AND 58 FEMALES) IN THE AGE GROUP OF 20 TO 60 YEARS, WHO PRACTICED YOGA REGULARLY FOR OVER FIVE YEARS FOR A PERIOD OF ONE HOUR DAILY, PERFORMED A BOUT OF MODERATE EXERCISE AND A BOUT OF STRENUOUS EXERCISE AS PER STANDARDIZED SHUTTLE WALK TEST PROTOCOL. ANTHROPOMETRICALLY MATCHED, AGE MATCHED AND GENDER MATCHED SUBJECTS, WHO DID NOT PRACTICE YOGA (NON-YOGA GROUP) WERE CHOSEN AS CONTROLS (NON-YOGA, N=109). THE NON-YOGA GROUP ALSO PERFORMED SIMILAR EXERCISES. THE BLOOD SAMPLES OF BOTH THE GROUPS WERE COLLECTED BEFORE AND AFTER THE EXERCISES. TNF-ALPHA AND IL-6 WAS ANALYSED BEFORE AND AFTER THE EXERCISE BY SANDWICH ELISA (ENZYME LINKED IMMUNOSORBENT ASSAY). RESULTS: RESTING PLASMA TNF-ALPHA CONCENTRATION WAS SIGNIFICANTLY HIGHER IN NON-YOGA GROUP WHEN COMPARED TO YOGA GROUP (P<0.05). THERE WAS AN INCREASE IN TNF-ALPHA LEVELS IN BOTH THE GROUPS IN RESPONSE TO STRENUOUS EXERCISE. THERE WAS NO GENDER DIFFERENCE IN TNF-ALPHA AND IL-6 LEVELS BEFORE AND AFTER EXERCISE IN YOGA AND NON-YOGA GROUPS. CONCLUSION: REGULAR PRACTICE OF YOGA LOWERS BASAL TNF-ALPHA AND IL-6 LEVELS. IT ALSO REDUCES THE EXTENT OF INCREASE OF TNF-ALPHA AND IL-6 TO A PHYSICAL CHALLENGE OF MODERATE EXERCISE AND STRENUOUS EXERCISE. THERE IS NO SIGNIFICANT GENDER DIFFERENCE IN THE TNF-ALPHA AND IL-6 LEVELS. REGULAR PRACTICE OF YOGA CAN PROTECT THE INDIVIDUAL AGAINST INFLAMMATORY DISEASES BY FAVOURABLY ALTERING PRO-INFLAMMATORY CYTOKINE LEVELS. 2015 7 1014 26 EFFECTS OF PILATES AND YOGA IN PATIENTS WITH CHRONIC NECK PAIN: A SONOGRAPHIC STUDY. BACKGROUND: VARIOUS STUDIES HAVE SHOWN THE EFFICACY OF CONVENTIONAL ISOMETRIC, PILATES AND YOGA EXERCISES. HOWEVER, DATA ON THE EFFECTS AND COMPARISON OF THESE SPECIFIC EXERCISES ON THE CERVICAL MUSCLE MORPHOLOGY ARE INSUFFICIENT OR LACKING. OBJECTIVE: TO INVESTIGATE THE EFFECTS OF DIFFERENT EXERCISE TREATMENTS ON NECK MUSCLES IN PATIENTS WITH CHRONIC NECK PAIN. DESIGN: A RANDOMIZED STUDY. METHODS: FIFTY-SIX PATIENTS WITH CHRONIC NECK PAIN WERE RANDOMIZED INTO 3 GROUPS AS FOLLOWS: PILATES GROUP (N = 20), YOGA GROUP (N = 18) AND ISOMETRIC GROUP (N = 18). DEMOGRAPHICS AND BACKGROUND INFORMATION WERE RECORDED. THE THICKNESS AND CROSS-SECTIONAL AREA OF NECK MUSCLES WERE EVALUATED BY ULTRASOUND IMAGING. CERVICAL MOTIONS WERE MEASURED WITH A GONIOMETER. PAIN SEVERITY WAS EVALUATED WITH THE MCGILL PAIN SCALE, DISABILITY WITH THE NECK DISABILITY INDEX, QUALITY OF LIFE WITH THE NOTTINGHAM HEALTH PROFILE, AND EMOTIONAL STATUS WITH THE BECK DEPRESSION INVENTORY. IN ADDITION TO A CONVENTIONAL PHYSIO-THERAPY PROGRAMME, 15 SESSIONS OF PHYSICAL THERAPY, INCLUDING HOT PACK, ULTRASOUND, AND TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS), WERE PROVIDED TO ALL PATIENTS. ALL GROUPS PERFORMED THE EXERCISES FOR 6 WEEKS. THE AFOREMENTIONED ASSESSMENTS WERE PERFORMED BEFORE AND 6 WEEKS AFTER THE TREATMENT. RESULTS: ALTHOUGH PAIN, DISABILITY, DEPRESSION AND QUALITY OF LIFE IMPROVED SIMILARLY WITHIN ALL GROUPS (ALL P < 0.05), MUSCLE THICKNESS VALUES AS REGARDS THE SEMISPINALIS CAPITIS WERE INCREASED ONLY IN THE PILATES GROUP (P = 0.022). STUDY LIMITATIONS: THE LACK OF COMPLEX (PROGRESSIVE RESISTIVE) EXERCISE TREATMENT PROTOCOLS, SHORT TREATMENT DURATION AND PARTIAL SUPERVISION. CONCLUSION: ALL 3 TYPES OF EXERCISE HAD FAVOURABLE EFFECTS ON PAIN AND FUNCTIONAL SCORES, BUT NO DIFFERENCES WERE FOUND AMONG THE GROUPS, EXCEPT FOR THE PILATES GROUP, IN WHICH THE SEMISPINALIS CAPITIS MUSCLE INCREASED IN THICKNESS. 2018 8 2594 30 YOGA FOR METABOLIC SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS. BACKGROUND METABOLIC SYNDROME IS THE MOST IMPORTANT RISK FACTOR FOR DEVELOPING CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND PERFORM A META-ANALYSIS OF THE EFFECTS OF YOGA ON THE PARAMETERS OF METABOLIC SYNDROME. METHODS MEDLINE/PUBMED, SCOPUS, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS AND INDMED WERE SEARCHED AND SCREENED FROM THEIR INCEPTION THROUGH TO 8 MARCH 2016 FOR RANDOMISED CONTROLLED TRIALS ON YOGA FOR PATIENTS WITH METABOLIC SYNDROME. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. RESULTS SEVEN TRIALS WITH A TOTAL OF 794 PARTICIPANTS WERE INCLUDED. NO EFFECTS OF YOGA ON RESOLUTION OF METABOLIC SYNDROME, DIASTOLIC BLOOD PRESSURE, TRIGLYCERIDES, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND FASTING PLASMA GLUCOSE WERE FOUND, BUT YOGA WAS SUPERIOR TO USUAL CARE FOR WAIST CIRCUMFERENCE (STANDARDISED MEAN DIFFERENCE (SMD) = -0.35; 95% CONFIDENCE INTERVAL (CI) = -0.57 TO -0.13; P < 0.01) AND SYSTOLIC BLOOD PRESSURE (SMD = -0.29; 95% CI = -0.51 TO -0.07; P = 0.01). HOWEVER, THESE EFFECTS WERE NOT ROBUST AGAINST SELECTION BIAS. NO INTERVENTION-RELATED ADVERSE EVENTS WERE REPORTED. CONCLUSION BASED ON THE RESULTS OF THIS META-ANALYSIS, NO RECOMMENDATION CAN BE MADE FOR OR AGAINST YOGA IN ORDER TO INFLUENCE THE PARAMETERS OF METABOLIC SYNDROME. DESPITE METHODOLOGICAL DRAWBACKS, AND UNTIL FURTHER RESEARCH IS UNDERTAKEN, YOGA CAN BE PRELIMINARILY CONSIDERED AS A SAFE AND EFFECTIVE INTERVENTION FOR REDUCING WAIST CIRCUMFERENCE AND SYSTOLIC BLOOD PRESSURE IN INDIVIDUALS WITH METABOLIC SYNDROME WHO ARE NOT ADHERING TO CONVENTIONAL FORMS OF EXERCISE. 2016 9 2617 31 YOGA FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. OBJECTIVES: YOGA HAS BEEN WIDELY PRACTICED AND HAS RECENTLY SHOWN BENEFITS IN PATIENTS WITH CORONARY HEART DISEASE (CHD), HOWEVER, EVIDENCE IS INCONSISTENT. METHODS: WE CONDUCTED A SYSTEMATIC REVIEW AND META-ANALYSIS BY SEARCHING PUBMED/MEDLINE, THE COCHRANE CENTRAL REGISTER OF CONTROLLED TRIALS (CENTRAL), EMBASE AND WEB OF SCIENCE FROM INCEPTION TO MAY 31, 2020 FOR RANDOMISED CONTROLLED TRIALS (RCTS) COMPARING YOGA WITH USUAL CARE OR NON-PHARMACOLOGICAL INTERVENTIONS IN PATIENTS WITH CHD. THE PRIMARY OUTCOMES WERE ALL-CAUSE MORTALITY AND HEALTH RELATED QUALITY OF LIFE (HR-QOL). SECONDARY OUTCOMES WERE A COMPOSITE CARDIOVASCULAR OUTCOME, EXERCISE CAPACITY AND CARDIOVASCULAR RISK FACTORS (BLOOD PRESSURE, LIPID PROFILES AND BODY MASS INDEX). RESULTS: SEVEN RCTS WITH A TOTAL OF 4671 PARTICIPANTS WERE INCLUDED. SIX RCTS COMPARED YOGA WITH USUAL CARE AND ONE COMPARED YOGA WITH DESIGNED EXERCISE. THE MEAN AGE OF THE PARTICIPANTS RANGED FROM 51.0-60.7 YEARS AND THE MAJORITY OF THEM WERE MEN (85.4 %). POOLED RESULTS SHOWED THAT COMPARED WITH USUAL CARE, YOGA HAD NO EFFECT ON ALL-CAUSE MORTALITY (RR, 1.02; 95 % CI, 0.75-1.39), BUT IT SIGNIFICANTLY IMPROVED HR-QOL (SMD, 0.07; 95 % CI, 0.01 - 0.14). A NON-SIGNIFICANT REDUCTION OF THE COMPOSITE CARDIOVASCULAR OUTCOME WAS OBSERVED (133 VS. 154; RR, 0.63; 95 % CI, 0.15-2.59). SERUM LEVEL OF TRIGLYCERIDE AND HIGH DENSITY LIPOPROTEIN CHOLESTEROL, BLOOD PRESSURE AND BODY MASS INDEX WERE ALSO SIGNIFICANTLY IMPROVED. THE STUDY COMPARING YOGA WITH CONTROL EXERCISE ALSO REPORTED SIGNIFICANTLY BETTER EFFECTS OF YOGA ON HR-QOL (85.75 VS. 75.24, P < 0.001). NO SEVERE ADVERSE EVENTS RELATED TO YOGA WERE REPORTED. CONCLUSIONS: YOGA MIGHT BE A PROMISING ALTERNATIVE FOR PATIENTS WITH CHD AS IT IS ASSOCIATED WITH IMPROVED QUALITY OF LIFE, LESS NUMBER OF COMPOSITE CARDIOVASCULAR EVENTS, AND IMPROVED CARDIOVASCULAR RISK FACTORS. 2021 10 1034 29 EFFECTS OF YOGA IN DAILY LIFE PROGRAM IN RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO EXPLORE THE FEASIBILITY AND EFFECTIVENESS OF A YOGA PROGRAM IN IMPROVING HEALTH-RELATED QUALITY OF LIFE (HQOL), PHYSICAL AND PSYCHOLOGICAL FUNCTIONING IN RHEUMATOID ARTHRITIS (RA) PATIENTS. DESIGN: SINGLE-CENTRE PARALLEL-ARMS RANDOMIZED CONTROLLED TRIAL COMPARING YOGA (N = 30) AND EDUCATION CONTROL GROUP (N = 27). SETTING: TERTIARY CARE UNIVERSITY HOSPITAL. INTERVENTION: A 12-WEEK YOGA PROGRAM, BASED ON THE YOGA IN DAILY LIFE SYSTEM, INCLUDED 2X WEEKLY/90-MINUTE SESSIONS. THE CONTROL GROUP HAD 1XWEEKLY/60-MINUTE EDUCATIONAL LECTURES ON ARTHRITIS-RELATED TOPICS. MAIN OUTCOME MEASURES: ASSESSMENTS WERE PERFORMED AT BASELINE, 12 (POST-INTERVENTION) AND 24 WEEKS (FOLLOW-UP). THE PRIMARY OUTCOME WAS CHANGE IN THE SHORT FORM-36 (SF-36) HQOL AT 12 WEEKS. LINEAR REGRESSION ANALYSIS WAS ADJUSTED FOR BASELINE SCORES. RESULTS: NO SIGNIFICANT BETWEEN-GROUP DIFFERENCES WERE FOUND FOR SF-36 (ALL P > 0.05). AT 12 WEEKS THE ADJUSTED MEAN DIFFERENCE BETWEEN GROUPS FAVOURED YOGA FOR FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY-FATIGUE (5.08 CI 1.29 TO 8.86; P = 0.009) AND HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)-DEPRESSION (-1.37 CI -2.38 TO -0.36); P = 0.008) AND AT 24 WEEKS FOR HADS-ANXIETY (-1.79 CI -3.34 TO - 0.23; P = 0.025), WHILE THE IMPACT ON FATIGUE WAS SUSTAINED (5.43 CI 1.33 TO 9.54, P = 0.01). THE PROGRAM HAD NO IMPACT ON RA DISEASE ACTIVITY. FEASIBILITY OUTCOMES INCLUDED RECRUITMENT RATE 16 %, RETENTION 80.7 %, AND ADHERENCE TO YOGA 87.5 VS 82.7 % FOR CONTROL. NO SERIOUS ADVERSE EVENTS WERE RECORDED. CONCLUSIONS: YOGA IN DAILY LIFE PROGRAM WAS NOT ASSOCIATED WITH CHANGE IN HEALTH-RELATED QUALITY OF LIFE OF RA PATIENTS. SIGNIFICANT IMPROVEMENTS IN FATIGUE AND MOOD WERE OBSERVED AT POSTINTERVENTION AND FOLLOW-UP. THIS YOGA PROGRAM WAS FOUND FEASIBLE AND SAFE FOR PATIENTS AND MAY COMPLEMENT STANDARD RA TREAT-TO-TARGET STRATEGY. 2021 11 2118 37 THE EFFECT OF YOGA PRACTICE ON GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS IN THE PREDIABETIC STATE: A SYSTEMATIC REVIEW AND META-ANALYSIS. A SYSTEMATIC REVIEW AND META-ANALYSIS WAS CONDUCTED TO INVESTIGATE THE EFFECTS OF YOGA ON GLYCEMIC CONTROL, LIPID PROFILES, BODY COMPOSITION AND BLOOD PRESSURE IN PEOPLE IN THE PRE-DIABETIC STATE. STUDIES ON THE EFFECTIVENESS OF YOGA ON POPULATION GROUPS UNDER HIGH RISK FOR DIABETES, CALLED PREDIABETIC OR SUFFERING FROM METABOLIC SYNDROMES WERE EXTRACTED FROM A THOROUGH SEARCH OF PUBMED, SCOPUS, COCHRANE LIBRARY, EBSCO AND INDMED DATABASES. BOTH RANDOMISED CONTROLLED TRIAL (RCT) AND NON-RCT STUDIES WERE INCLUDED IN THE SYSTEMATIC REVIEW AND META-ANALYSIS. STUDIES PUBLISHED BETWEEN JAN 2002 AND DEC 2018 WERE INCLUDED. STUDIES WERE CONSIDERED FOR EVALUATION IF THEY INVESTIGATED A YOGA INTERVENTION TO PREVENT T2DM, AGAINST A CONTROL GROUP, WHILE ALSO REPORTING GLYCEMIC CONTROL AND OTHER HEALTH PARAMETERS OF T2DM MANAGEMENT. SUMMARY EFFECT SIZES AND 95% CONFIDENCE INTERVALS (CI) WERE CALCULATED USING THE COMPREHENSIVE META-ANALYSIS SOFTWARE IN ADDITION TO PUBLICATION BIAS. OF THE 46,500 IDENTIFIED STUDIES, 14 STUDIES WITH 834 PARTICIPANTS OF WHOM WERE 50% WOMEN, WERE FOUND TO BE ELIGIBLE FOR INCLUSION IN OUR SYSTEMATIC REVIEW. OUR QUANTITATIVE SYNTHESIS INCLUDED 12 RANDOMIZED CONTROL TRIALS AND 2 NON-RANDOMIZED CONTROL TRIALS, WITH THE FOLLOW-UP PERIOD RANGING FROM 4 TO 52 WEEKS. COMPARED TO CONTROLS, YOGA INTERVENTION IMPROVED FASTING BLOOD GLUCOSE (FBG) [STANDARD MEAN DIFFERENCE (SMD -0.064 MG/DL (95% CI -0.201 TO 0.074)]; LOW DENSITY LIPOPROTEIN (LDL) [SMD-0.090 MG/DL (95% CI -0.270 TO 0.090)]; TRIGLYCERIDES [SMD -0.148 MG/DL (95% CI -0.285 TO -0.012)]; TOTAL CHOLESTEROL [SMD -0.058 MG/DL (95% CI -0.220 TO 0.104)] AND SYSTOLIC BLOOD PRESSURE [SMD -0.058 MM HG (95% CI -0.168 TO 0.053)]. THIS META-ANALYSIS UNCOVERED CLINICALLY IMPROVED EFFECTS OF YOGA INTERVENTION ON GLYCEMIC CONTROL, LIPID PROFILES AND OTHER PARAMETERS OF T2DM MANAGEMENT IN PREDIABETIC POPULATION. THESE RESULTS SUGGEST THAT YOGA INTERVENTION MAY BE CONSIDERED AS A COMPREHENSIVE AND ALTERNATIVE APPROACH TO PREVENTING T2DM. FURTHER ADEQUATELY POWERED, WELL DESIGNED RCTS ARE NEEDED TO SUPPORT OUR FINDINGS AND INVESTIGATE THE LONG-TERM EFFECTS OF YOGA IN T2DM PATIENTS. 2019 12 206 20 A SELF-DIRECTED HOME YOGA PROGRAMME FOR WOMEN WITH BREAST CANCER DURING CHEMOTHERAPY: A FEASIBILITY STUDY. RECENT STUDIES SUGGEST YOGA AS A PROMISING APPROACH FOR IMPROVING THE COGNITIVE FUNCTION OF CANCER SURVIVORS. WE STUDIED WHETHER A SELF-DIRECTED HOME YOGA PROGRAMME WAS FEASIBLE FOR PATIENTS WITH BREAST CANCER WHO WERE UNDERGOING CHEMOTHERAPY. PARTICIPANTS' PREFERENCES FOR THE TYPE OF YOGA COURSE AND THE CLINICAL EFFECTS OF THE PROGRAMME WERE ALSO ASSESSED. IN THIS STUDY, 18 WOMEN (MEAN AGE, 43.9 YEARS) WERE ENROLLED (44.7% RECRUITMENT RATE). OF THE PARTICIPANTS, 63.6% HAD STAGE II CANCER AND 71.4% RECEIVED ADJUVANT CHEMOTHERAPY. FAVOURABLE RETENTION (86%), ADHERENCE (94.4%) AND ACCEPTABILITY (96.5%) RATES WERE DETERMINED. MOST (94.4%) OF THE WOMEN PRACTICED THE HOME PROGRAMME MORE THAN TWICE A WEEK ON AVERAGE. THE PARTICIPANTS PREFERRED TO GRADUALLY INCREASE THE INTENSITY OF THE EXERCISES. WE ONLY OBSERVED IMPROVEMENTS IN THE COGNITIVE ASPECTS OF FATIGUE. NO SERIOUS ADVERSE EVENTS WERE ENCOUNTERED DURING THE PROGRAMME. THIS SELF-DIRECTED HOME YOGA PROGRAMME WAS SAFE AND FEASIBLE FOR PATIENTS WITH BREAST CANCER UNDERGOING CHEMOTHERAPY. 2016 13 220 18 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA AND MINDFULNESS MEDITATION IN PRISON. THIS ARTICLE PRESENTS RESULTS FROM A SYSTEMATIC REVIEW AND TWO META-ANALYSES THAT EXAMINE WHETHER PRISON YOGA AND MEDITATION PROGRAMS ARE SIGNIFICANTLY RELATED TO INCREASED PSYCHOLOGICAL WELL-BEING AND IMPROVEMENTS IN THE BEHAVIOURAL FUNCTIONING OF PRISONERS. COMPREHENSIVE SEARCHES OF THE EMPIRICAL LITERATURE WERE CONDUCTED UP TO DECEMBER 2014. PARTICIPANTS WHO COMPLETED YOGA OR MEDITATION PROGRAM IN PRISON EXPERIENCED A SMALL INCREASE IN THEIR PSYCHOLOGICAL WELL-BEING (COHEN'S D = 0.46, 95% CONFIDENCE INTERVAL [CI] = [0.39, 0.54]) AND A SMALL IMPROVEMENT IN THEIR BEHAVIOURAL FUNCTIONING (COHEN'S D = 0.30, 95% CI = [0.20, 0.40]). MODERATOR ANALYSES SUGGESTED THAT THERE WAS A SIGNIFICANT DIFFERENCE IN EFFECT SIZES FOR PROGRAMS OF LONGER DURATION AND LESS INTENSITY, COMPARED WITH THOSE THAT WERE SHORTER AND MORE INTENSIVE, FOR PSYCHOLOGICAL WELL-BEING. PROGRAMS OF LONGER DURATION HAD A SLIGHTLY LARGER POSITIVE EFFECT ON BEHAVIOURAL FUNCTIONING ( D = 0.424), COMPARED WITH MORE INTENSIVE PROGRAMS ( D = 0.418). OVERALL, THE EVIDENCE SUGGESTS THAT YOGA AND MEDITATION HAVE FAVOURABLE EFFECTS ON PRISONERS. 2017 14 926 38 EFFECTIVENESS OF YOGA LIFESTYLE ON LIPID METABOLISM IN A VULNERABLE POPULATION-A COMMUNITY BASED MULTICENTER RANDOMIZED CONTROLLED TRIAL. BACKGROUND: DYSLIPIDEMIA POSES A HIGH RISK FOR CARDIOVASCULAR DISEASE AND STROKE IN TYPE 2 DIABETES (T2DM). THERE ARE NO STUDIES ON THE IMPACT OF A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL ON LIPID PROFILES IN A HIGH-RISK DIABETES POPULATION. METHODS: HERE, WE REPORT THE RESULTS OF LIPID PROFILE VALUES OF 11,254 (YOGA 5932 AND CONTROL 5322) ADULTS (20-70 YEARS) OF BOTH GENDERS WITH HIGH RISK (>/=60 ON INDIAN DIABETES RISK SCORE) FOR DIABETES FROM A NATIONWIDE RURAL AND URBAN COMMUNITY-BASED TWO GROUP (YOGA AND CONVENTIONAL MANAGEMENT) CLUSTER RANDOMIZED CONTROLLED TRIAL. THE YOGA GROUP PRACTICED A VALIDATED INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) IN NINE DAY CAMPS FOLLOWED BY DAILY ONE-HOUR PRACTICE. BIOCHEMICAL PROFILING INCLUDED GLYCATED HEMOGLOBIN AND LIPID PROFILES BEFORE AND AFTER THREE MONTHS. RESULTS: THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN GROUPS (P < 0.001 ANCOVA) WITH IMPROVED SERUM TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND HIGH-DENSITY LIPOPROTEIN IN THE YOGA GROUP COMPARED TO THE CONTROL GROUP. FURTHER, THE REGULATORY EFFECT OF YOGA WAS NOTED WITH A SIGNIFICANT DECREASE OR INCREASE IN THOSE WITH HIGH OR LOW VALUES OF LIPIDS, RESPECTIVELY, WITH MARGINAL OR NO CHANGE IN THOSE WITHIN THE NORMAL RANGE. CONCLUSION: YOGA LIFESTYLE IMPROVES AND REGULATES (LOWERED IF HIGH, INCREASED IF LOW) THE BLOOD LIPID LEVELS IN BOTH GENDERS OF PREDIABETIC AND DIABETIC INDIVIDUALS IN BOTH RURAL AND URBAN INDIAN COMMUNITIES. 2021 15 2171 25 THE EFFECTS OF YOGA ON CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: SYSTEMATIC REVIEW AND META-ANALYSIS. TYPE 2 DIABETES MELLITUS (T2DM) IS A FASTEST EVOLVING METABOLIC DISORDER AND INDIA HOUSES SECOND HIGHEST NUMBER OF PATIENTS WITH DIABETES AFTER CHINA. CARDIOVASCULAR DISEASES ARE THE MAJOR CAUSE OF MORTALITY AMONG PATIENTS WITH T2DM. YOGA IS AN ANCIENT INDIAN PRACTICE THAT PROVES TO BE EFFECTIVE FOR PATIENTS WITH DIABETES. THE PRESENT SYSTEMATIC REVIEW AND META-ANALYSIS HAS BEEN CONDUCTED TO SEE THE BENEFITS OF YOGA ON BLOOD PRESSURE, LIPID PROFILE, AND ANTHROPOMETRIC MEASURES AMONG PATIENTS WITH T2DM. THE ARTICLES WERE EXTRACTED FROM THREE DATABASES - PUBMED, THE COCHRANE LIBRARY, AND GOOGLE SCHOLAR. ONLY ENGLISH LANGUAGE ARTICLES, WITH PEDRO SCORE>/=6, WERE INCLUDED IN THE CURRENT STUDY. THE DUPLICATES WERE REMOVED USING MENDELEY. FOURTEEN RANDOMIZED CONTROLLED TRIALS (RCTS) AND THREE 3 NON-RCTS WERE INCLUDED IN THE ANALYSIS. THE META-ANALYSIS WAS DONE USING REVIEW MANAGER 5.3. THE RESULTS REVEAL THAT YOGA IS EFFECT IN IMPROVING BLOOD PRESSURE (P<0.01), LIPID PROFILE (P<0.01) EXCEPT HDL (P=0.06), AND ANTHROPOMETRIC MEASURES (P<0.01) EXCEPT WAIST-HIP RATIO (P=0.79). HETEROGENEITY WAS ALSO HIGH FOR MOST OF THE VARIABLES. IT MAY BE CONCLUDED FROM THE RESULTS THAT THE YOGA IS EFFECTIVE IN IMPROVING OF BLOOD PRESSURE, LIPID PROFILE, AND ANTHROPOMETRIC MEASURES. HOWEVER, HIGH HETEROGENEITY SOUGHT THE NEED OF MORE HIGH QUALITY RCTS TO AFFIRM THESE FINDINGS. 2022 16 221 26 A SYSTEMATIC REVIEW AND META-ANALYSIS OF YOGA FOR HYPERTENSION. BACKGROUND: THE AIM OF THIS SYSTEMATIC REVIEW AND META-ANALYSIS WAS TO EVALUATE THE QUALITY OF EVIDENCE AND THE STRENGTH OF RECOMMENDATION FOR YOGA AS A THERAPEUTIC MEANS IN THE MANAGEMENT OF PREHYPERTENSION AND HYPERTENSION. METHODS: MEDLINE/PUBMED, SCOPUS, CENTRAL, AND INDMED WERE SCREENED THROUGH FEBRUARY 2014 FOR RANDOMIZED CONTROLLED TRIALS (RCTS) ON THE EFFECTS OF YOGA INTERVENTIONS (>/=8 WEEKS) COMPARED WITH USUAL CARE OR ANY ACTIVE CONTROL INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH PREHYPERTENSION (120-139/80-89 MM HG) OR HYPERTENSION (>/=140/>/=90 MM HG). RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL; QUALITY OF EVIDENCE WAS ASSESSED ACCORDING TO THE GRADE RECOMMENDATIONS. RESULTS: SEVEN RCTS WITH A TOTAL OF 452 PATIENTS WERE INCLUDED. COMPARED WITH USUAL CARE, VERY LOW-QUALITY EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC (6 RCTS, N = 278; MEAN DIFFERENCE (MD) = -9.65 MM HG, 95% CONFIDENCE INTERVAL (CI) = -17.23 TO -2.06, P = 0.01; HETEROGENEITY: I (2) = 90%, CHI(2) = 48.21, P < 0.01) AND DIASTOLIC BLOOD PRESSURE (6 RCTS, N = 278; MD = -7.22 MM HG, 95% CI = -12.83 TO -1.62, P = 0.01; HETEROGENEITY: I (2) = 92%, CHI(2) = 64.84, P < 0.01). SUBGROUP ANALYSES REVEALED EFFECTS FOR RCTS THAT INCLUDED HYPERTENSIVE PATIENTS BUT NOT FOR RCTS THAT INCLUDED BOTH HYPERTENSIVE AND PREHYPERTENSIVE PATIENTS, AS WELL AS FOR RCTS THAT ALLOWED ANTIHYPERTENSIVE COMEDICATION BUT NOT FOR THOSE THAT DID NOT. MORE ADVERSE EVENTS OCCURRED DURING YOGA THAN DURING USUAL CARE. COMPARED WITH EXERCISE, NO EVIDENCE WAS FOUND FOR EFFECTS OF YOGA ON SYSTOLIC OR DIASTOLIC BLOOD PRESSURE. CONCLUSIONS: LARGER STUDIES ARE REQUIRED TO CONFIRM THE EMERGING BUT LOW-QUALITY EVIDENCE THAT YOGA MAY BE A USEFUL ADJUNCT INTERVENTION IN THE MANAGEMENT OF HYPERTENSION. 2014 17 223 20 A SYSTEMATIC REVIEW AND META-ANALYSIS ON THE EFFECTS OF YOGA ON WEIGHT-RELATED OUTCOMES. INTRODUCTION: OVERWEIGHT AND OBESITY ARE AMONG THE MOST IMPORTANT MODIFIABLE RISK FACTORS FOR CHRONIC DISEASES AND PREMATURE DEATH. THE AIM OF THIS REVIEW WAS TO SYSTEMATICALLY ASSESS AND ANALYZE THE EFFECTS OF YOGA ON WEIGHT-RELATED OUTCOMES. METHODS: MEDLINE/PUBMED, SCOPUS, AND THE COCHRANE LIBRARY WERE SCREENED THROUGH MARCH 2015 FOR RANDOMIZED CONTROLLED TRIALS ON YOGA FOR WEIGHT-RELATED OUTCOMES IN THE GENERAL POPULATION OR OVERWEIGHT/OBESE INDIVIDUALS. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL ON THE FOLLOWING DOMAINS: SELECTION BIAS, PERFORMANCE BIAS, DETECTION BIAS, ATTRITION BIAS, REPORTING BIAS, AND OTHER BIAS. RESULTS: OUT OF 445 RECORDS IDENTIFIED DURING LITERATURE SEARCH, 30 TRIALS WITH A TOTAL OF 2173 PARTICIPANTS WERE INCLUDED. NO EFFECTS ON WEIGHT, BODY MASS INDEX, BODY FAT PERCENTAGE OR WAIST CIRCUMFERENCE WERE FOUND. IN STUDIES WITH HEALTHY ADULT PARTICIPANTS AN EFFECT OF YOGA COMPARED TO USUAL CARE WAS FOUND REGARDING WAIST/HIP RATIO (SMD=--1.00; 95% CI=--1.44, -0.55; P<0.001). IN STUDIES WITH OVERWEIGHT/OBESE PARTICIPANTS ONLY, EFFECTS RELATIVE TO USUAL CARE WERE FOUND FOR BODY MASS INDEX (SMD=-0.99; 95% CI=-1.67, -0.31; P=0.004). EFFECTS HOWEVER WERE NOT ROBUST AGAINST SELECTION BIAS; AND PUBLICATION BIAS COULD NOT BE RULED OUT. NO INTERVENTION-RELATED ADVERSE EVENTS WERE REPORTED. CONCLUSIONS: DESPITE METHODOLOGICAL DRAWBACKS, YOGA CAN BE PRELIMINARILY CONSIDERED A SAFE AND EFFECTIVE INTERVENTION TO REDUCE BODY MASS INDEX IN OVERWEIGHT OR OBESE INDIVIDUALS. 2016 18 1104 25 EFFECTS OF YOGA VERSUS SHAM YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS: A SINGLE-BLINDED RANDOMIZED PILOT STUDY. STUDIES HAVE SHOWN A BENEFICIAL ROLE OF YOGA IN TRE A T I N G TYPE 2 DIABETES MELLITUS. THE PRESENT STUDY PROCEEDS IN THE FIELD BY PROVIDING AN ACTIVE CONTROL. WE AIMED TO EVALUATE THE EFFECT OF 3 MONTHS OF YOGA ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. FORTY PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER YOGA (N = 20) OR SHAM YOGA (N = 20) AS A CONTROL. YOGA INCLUDED POSTURES AND BREATHING EXERCISES, AND NONAEROBIC STRETCHING EXERCISE COMPRISED THE CONTROL. SIGNIFICANT WITHIN-GROUP DIFFERENCES IN MALONDIALDEHYDE, VITAMIN C, SUPEROXIDE DISMUTASE, FASTING BLOOD GLUCOSE, GLYCOSYLATED HEMOGLOBIN, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND BLOOD PRESSURE WERE EVIDENT IN BOTH GROUPS. YOGA PARTICIPANTS HAD SIGNIFICANTLY GREATER IMPROVEMENT IN REDUCED GLUTATHIONE COMPARED TO CONTROLS. NO SIGNIFICANT DIFFERENCES BETWEEN GROUPS WERE OBSERVED IN ANY OTHER OUTCOME VARIABLES. YOGA AND SHAM YOGA HAD IDENTICAL EFFECTS ON OXIDATIVE STRESS, GLYCEMIC STATUS, AND ANTHROPOMETRY IN TYPE 2 DIABETES MELLITUS. LEVELS OF REDUCED GLUTATHIONE IMPROVED ONLY IN THE YOGA GROUP. THIS RESEARCH NEEDS TO BE CONFIRMED BY LARGER AND SUFFICIENTLY POWERED STUDIES. 2020 19 2634 29 YOGA FOR TREATING LOW BACK PAIN: A SYSTEMATIC REVIEW AND META-ANALYSIS. ABSTRACT: YOGA IS FREQUENTLY USED FOR BACK PAIN RELIEF. HOWEVER, THE EVIDENCE WAS JUDGED TO BE OF ONLY LOW TO MODERATE CERTAINTY. TO ASSESS THE EFFICACY AND SAFETY OF YOGA IN PATIENTS WITH LOW BACK PAIN, A META-ANALYSIS WAS PERFORMED. THEREFORE, MEDLINE/PUBMED, SCOPUS, AND THE COCHRANE LIBRARY WERE SEARCHED TO MAY 26, 2020. ONLY RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH PASSIVE CONTROL (USUAL CARE OR WAIT LIST), OR AN ACTIVE COMPARATOR, FOR PATIENTS WITH LOW BACK PAIN AND THAT ASSESSED PAIN INTENSITY OR PAIN-RELATED DISABILITY AS A PRIMARY OUTCOME WERE CONSIDERED TO BE ELIGIBLE. TWO REVIEWERS INDEPENDENTLY EXTRACTED DATA ON STUDY CHARACTERISTICS, OUTCOME MEASURES, AND RESULTS AT SHORT-TERM AND LONG-TERM FOLLOW-UP. RISK OF BIAS WAS ASSESSED USING THE COCHRANE RISK OF BIAS TOOL. THIRTY ARTICLES ON 27 INDIVIDUAL STUDIES (2702 PARTICIPANTS IN TOTAL) PROVED ELIGIBLE FOR REVIEW. COMPARED WITH PASSIVE CONTROL, YOGA WAS ASSOCIATED WITH SHORT-TERM IMPROVEMENTS IN PAIN INTENSITY (15 RCTS; MEAN DIFFERENCE [MD] = -0.74 POINTS ON A NUMERIC RATING SCALE; 95% CONFIDENCE INTERVAL [CI] = -1.04 TO -0.44; STANDARDIZED MEAN DIFFERENCE [SMD] = -0.37 95% CI = -0.52 TO -0.22), PAIN-RELATED DISABILITY (15 RCTS; MD = -2.28; 95% CI = -3.30 TO -1.26; SMD = -0.38 95% CI = -0.55 TO -0.21), MENTAL HEALTH (7 RCTS; MD = 1.70; 95% CI = 0.20-3.20; SMD = 0.17 95% CI = 0.02-0.32), AND PHYSICAL FUNCTIONING (9 RCTS; MD = 2.80; 95% CI = 1.00-4.70; SMD = 0.28 95% CI = 0.10-0.47). EXCEPT FOR MENTAL HEALTH, ALL EFFECTS WERE SUSTAINED LONG-TERM. COMPARED WITH AN ACTIVE COMPARATOR, YOGA WAS NOT ASSOCIATED WITH ANY SIGNIFICANT DIFFERENCES IN SHORT-TERM OR LONG-TERM OUTCOMES. 2022 20 692 22 EFFECT OF COMMUNITY-BASED YOGA INTERVENTION ON OXIDATIVE STRESS AND GLYCEMIC PARAMETERS IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: TO STUDY THE EFFECTIVENESS OF YOGA INTERVENTION ON OXIDATIVE STRESS, GLYCEMIC STATUS, BLOOD PRESSURE AND ANTHROPOMETRY IN PREDIABETES. DESIGN: RANDOMIZED-CONTROLLED TRIAL. PARTICIPANTS: TWENTY NINE PREDIABETES SUBJECTS AGED 30-75 YEARS. SETTING: YOGA WAS CONDUCTED AT 4 DIFFERENT COMMUNITY DIABETES CLINICS IN MANGALORE, INDIA. INTERVENTIONS: PARTICIPANTS WERE RANDOMIZED TO EITHER 3-MONTH YOGA OR WAIT-LIST CONTROL GROUPS. MAIN OUTCOME MEASURES: MALONDIALDEHYDE, GLUTATHIONE, VITAMIN C, VITAMIN E, SUPEROXIDE DISMUTASE, PLASMA GLUCOSE, GLYCATED HAEMOGLOBIN, BMI, WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO AND BLOOD PRESSURE. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN MALONDIALDEHYDE (P<0.001), RELATIVE TO THE CONTROL GROUP. IN COMPARISON WITH THE CONTROL, THERE WAS A SIGNIFICANT IMPROVEMENT IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE LEVELS AT FOLLOW-UP. NO SIGNIFICANT IMPROVEMENT IN GLYCATED HAEMOGLOBIN, WAIST-TO-HIP RATIO OR ANY OF THE ANTIOXIDANTS WAS OBSERVED. CONCLUSIONS: YOGA INTERVENTION MAY BE HELPFUL IN CONTROL OF OXIDATIVE STRESS IN PREDIABETES SUBJECTS. YOGA CAN ALSO BE BENEFICIAL IN REDUCTION IN BMI, WAIST CIRCUMFERENCE, SYSTOLIC BLOOD PRESSURE AND FASTING GLUCOSE. EFFECT OF YOGA ON ANTIOXIDANT PARAMETERS WAS NOT EVIDENT IN THIS STUDY. THE FINDINGS OF THIS STUDY NEED TO BE CONFIRMED IN LARGER TRIALS INVOLVING ACTIVE CONTROL GROUPS. 2013